Two more drugs from meningitis-linked firm probed

Two more drugs from a specialty pharmacy linked to a meningitis outbreak are now being investigated, U.S. health officials said, as they urged doctors to contact patients who got any kind of injection of drugs made by the company. The New England Compounding Center of Framingham, Mass., has been under scrutiny since last month, when a rare fungal form of meningitis was linked to its steroid shots used mostly for back pain. Monday’s step by the Food and Drug Administration followed reports of infections in three people who got different drugs made by the company. One is a possible meningitis illness in a patient who got a spine injection of another type of steroid.